316
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

Carfilzomib as salvage therapy in Waldenstrom macroglobulinemia: a case series

, , , , , , , , & show all
Pages 259-261 | Received 26 Jan 2017, Accepted 14 Apr 2017, Published online: 05 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Karima Amaador, Marie J. Kersten, Monique C. Minnema & Josephine M. I. Vos. (2023) Treatment of relapsed and refractory Waldenstrom Macroglobulinemia. Leukemia & Lymphoma 64:1, pages 30-41.
Read now
Ramón García-Sanz, Cristina Jiménez, Verónica González De La Calle & María Eugenia Sarasquete. (2018) A safety profile of medications used to treat Waldenström’s macroglobulinemia. Expert Opinion on Drug Safety 17:6, pages 609-621.
Read now

Articles from other publishers (7)

Ramón García-Sanz & Alessandra Tedeschi. (2023) The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia. Hematology/Oncology Clinics of North America 37:4, pages 727-749.
Crossref
Karan L. Chohan & Prashant Kapoor. (2023) BTK Inhibitors and Other Targeted Therapies in Waldenström Macroglobulinemia. Hemato 4:2, pages 135-157.
Crossref
Zdeněk Adam, David Zeman, Luděk Pour, Marta Krejčí, Martin Krejčí, Zdeněk Řehák, Renata Koukalová, Viera Sandecká, Martin Štork, Gabriela Romanová, Zuzana Adamová & Zdeněk Král. (2022) Waldenström´s macroglobulinemia, overview of clinical symptoms, and therapy and our experience with ibrutinib therapy. Onkologie 16:Suppl. B, pages 83-102.
Crossref
Meletios A. Dimopoulos & Efstathios Kastritis. (2019) How I treat Waldenström macroglobulinemia. Blood 134:23, pages 2022-2035.
Crossref
Morie A. Gertz. (2019) Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology 94:2, pages 266-276.
Crossref
Efstathios Kastritis & Meletios A. Dimopoulos. (2018) Proteasome Inhibitors in Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America 32:5, pages 829-840.
Crossref
Morie A. Gertz. (2018) Waldenström macroglobulinemia treatment algorithm 2018. Blood Cancer Journal 8:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.